Abstract
Glaucoma is a leading cause of worldwide blindness. Treatment of this chronic disease, centered on lowering intraocular pressure (IOP), may require surgical intervention when medical and/or laser therapy fail to control IOP. Traditional glaucoma surgery, such as trabeculectomy, has been performed for decades and has a proven track record of success. Unfortunately, many complications such as hypotony and slow visual recovery are known to occur and can lead to significant patient morbidity. New devices are being developed to allow surgeons increased control with more predictable postoperative results. One such device, the Ex-PRESS™ mini glaucoma shunt, has undergone changes in design and method of insertion making it more appealing for use in patients requiring IOP-lowering surgery. We summarize pertinent literature and expand on the future role of this device in glaucoma surgery.
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
No writing assistance was utilized in the production of this manuscript.